| Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) | Life Technologies assists in establishing NASH conditions by modulating glucose, fructose, free fatty acids, and lipopolysaccharide (LPS) levels. | SC-ST00B |
| Cytotoxicity assays | |
| Cytokines analysis: IL-6, TNF-α, MIP-1α (CCL3), MCP-1, IP-10 (CXCL10), IL-8 (CXCL8) | |
| Expression of profibrotic markers | |
| Apoptosis marker studies | |
| Oxidative stress marker studies | |
| Mitochondrial dysfunction studies | |
| Cellular lipids and phospholipids estimation by LipidTox staining | |
| Miscellaneous based on customers requirement subject to Feasibility | |
| | |
